Skip to main content

ÚNICAS. Implantación de una Red Pediátrica de Medicina Personalizada en enfermedades raras pediátricas. Un proyecto piloto.

PMP22/00008

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal para Afrontar las Prioridades de Nuestro Entorno
Call Proyectos de Investigación de Medicina Personalizada de Precisión
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION Y DOCENCIA SANT JOAN DE DEU
Execution centre FUNDACION PARA LA INVESTIGACION Y DOCENCIA SANT JOAN DE DEU

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring Plasma Coenzyme Q10 Status in Paediatric Dyslipidaemia

  • Minguez, B.|||0000-0002-7699-3972
  • Paredes-Fuentes, Abraham J.|||0000-0002-7163-2385
  • Oliva, C.
  • Rodriguez-Gonzalez, H.
  • Santos Ocaña, Carlos|||0000-0002-2379-796X
  • Artuch, R.|||0000-0002-3422-9685
  • Santos, Mariela de los
  • Garcia-Volpe, Camila
  • Molera Busoms, Cristina
  • Arias, Angela
  • Yubero, Délia
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Meavilla, Silvia
Coenzyme Q10 (CoQ) is a ubiquitous lipid with different biological functions. In blood, there is a close relationship between CoQ status and cholesterol, which strongly supports the study of both molecules simultaneously. The objective of this study was to evaluate plasma CoQ, lipoprotein concentrations and CoQ/Chol ratio in a cohort of paediatric patients with different types of dyslipidaemias. A total of 60 paediatric patients were recruited (age range: 7 months-18 years), including 52 with different types of hypercholesterolemia, 2 with isolated hypertriglyceridemia and 6 with hypobetalipoproteinemia. Plasma CoQ was analysed by HPLC with electrochemical detection, and lipoprotein and cholesterol concentrations by standard automated methods. The lowest CoQ values were detected in patients with hypobetalipoproteinemia and in two cases of liver cirrhosis. Mean CoQ values were significantly higher in hypercholesterolemic patients compared to controls (average values 1.07 µmol/L and 0.63 µmol/L) while the CoQ/cholesterol ratio did not show differences (170 vs. 163, respectively). Mean CoQ values were significantly lower in the group of patients with hypobetalipoproteinemia compared to controls (mean CoQ values of 0.22 µmol/L vs. 0.63 µmol/L, respectively), while those of CoQ/cholesterol did not show differences. Pearson's correlation test showed a positive correlation between the CoQ and cholesterol values (r = 0.565, p < 0.001) and between the CoQ and the LDL cholesterol values (r = 0.610, p < 0.001). Our results suggest that it is advisable to analyse plasma CoQ and cholesterol concentrations in patients with hypobetalipoproteinemia and hypercholesterolemia associated with liver damage.